Gulf Pharmaceutical Industries P.S.C.

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Planet, Investments, and Others segment. The company offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract. It also provides solutions for type 1, type 2, and gestational diabetes, such as insulin formulations of recombinant human insulin and continuous glucose monitoring systems. In addition, the company is involved in the transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; and trading in medical equipment. Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.